| |
Dr. Manfred
Zoltobrocki
Geschäftsführer, Lux Biosciences GmbH, Frankfurt am Main, Deutschland
Dr.
Zoltobrocki is the Managing Director of Lux Biosciences GmbH. Dr.
Zoltobrocki brings 34 years of experience from the pharmaceutical and
biotechnology industries, where he held various positions in R&D and general
management.
Prior to
joining Lux Biosciences, Dr. Zoltobrocki served as Chief Executive Officer
of EPIDAUROS Biotechnologie AG, a pharmacogenetics company, from 2003 until
March 2006, where he managed the turnaround and a strategic reorientation.
Between 1996 and 2002, Dr. Zoltobrocki served as Vice President of
Development at Aventis Pharma, where he directed the drug development units
located in Germany including therapeutic areas like metabolism, infectious
diseases, neurology, cardiology, and others. Prior to that, he held various
positions in R&D management with the Aventis predecessor companies Hoechst
Marion Roussel and Hoechst Pharma.
Dr.
Zoltobrocki received his Ph.D. in biochemistry from the University of
Frankfurt am Main, and spent 2 years as a post-doctoral fellow at the
University of Iowa in the field of protein chemistry.
|
